| | JULY 20164Consultants Review | | June 20165Consultants Review | | June 20165Consultants ReviewVol 2 · Issue 6-2 · July -7 - 2016 Publisher & Editor Alok Chaturvedi Managing Editor Rachita Sharma GM-Sales & Marketing Rohit KumarEditorial Team Lithin Zacharia Saheli R Chowdhuri Shivali Sharma Aniruddh S K Group Art Director Ashok Kumar Sr. Visualiser Maitreyee Visualiser SivasankarAdvertisement Chander Shalini Kiran T : 080-43112102Delhi Ratnam Gupta T : 011-45992106editor@consultantsreview.com marketing@consultantsreview.comNo. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugheshpalya, Bangalore-560017 To subscribe: Circulation Manager Magendran Perumal T : 080-43112203subscription@consultantsreview.com Cover price Rs 100 per issue.Printed and Published By Alok Chaturvedi on Behalf of SiliconMedia Technologies Pvt Ltd and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 And Published At No. 124, 2Nd Floor, Surya Chambers, Old Airport Road, Murigheshpalya, Bangalore-560017. Copyright © 2016 SiliconMedia Technologies Pvt Ltd, All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.The Indian pharmaceutical market is a behemoth in the making. According to reports by the Indian government, the Indian pharmaceutical market size is expected to grow to US$ 100 billion by 2025. This growth will be fuelled by increase in consumer spending, rapid urbanization, and raising healthcare insurance. We are also the leading the race in terms of providing generic medicines globally, with a 20% share in supplies by volume. The Indian pharma market overtook the Red Dragon in terms of pharma exports. The country's pharma exports rose 7.55%, from $11.66 billion in 2014 to $12.54 billion in 2015 according to reports by the ministry of commerce and industry. The Indian pharma market has been charting a success story every year on. Going by the Indian Government's future plans to boost the pharmaceutical infrastructure, this growth will remain steady in the years to come. The Government of India plans to set up a US$ 640 million venture capital fund to boost drug discovery and strengthen pharmaceutical infrastructure. The `Pharma Vision 2020' by the government's Department of Pharmaceuticals aims to make India a major hub for end-to-end drug discovery.The growing cost of R&D, regulatory pressures and increase in demand for quality healthcare across the globe has been a boon for Indian Pharma companies that are making the most of the favorable market conditions. The pharma industry in India is being supported by seasoned consultants who are helping companies become more competitive and successful in today's evolving market. These consulting organizations help organizations strengthen the foundations for future growth and improve the effectiveness and efficiency of their current business operations. In a bid to help you chose the right pharma and biotech consultant to assist you in charting your growth story, our current edition brings to you a list of '25 Most Promising Pharma & BioTech Consultants'. So let us know your thoughts.Editor's NoteIndian Pharma Market is a Success Story in the MakingRachita Sharma Managing EditorConsultantsReview
< Page 3 | Page 5 >